ArticleJournal of drug assessment2013

Bioequivalence study of two subcutaneous formulations of dalteparin: randomized, single-dose, two-sequence, two-period, cross-over study in healthy volunteers.

C Gadiko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.